SavedAdd your journal

Journals / Genel Tıp Dergisi / 2019 / Cilt: 29 - Sayı: 1

Kalp hastalığı olmayan romatoid artritli hastalarda hastalık aktivitesi ile nt-pro bnp düzeyleri arasındaki ilişki

Sevcan UĞUR
Ayşegül KURTOĞLU
Bülent BÜTÜN
Pages
14–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a need for studies in a large number of patients and specific groups evaluating the relationship with disease activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cardiovascular features in rheumatoid arthritis (RA) are comman.
📊
Key Findings & Data:Material and Methods: Serum NT-proBNP, erythrocyte sedimentation rate, C-reactive protein levels were measured in 77 patients with RA and 31 healthy control groups without cardiac disease history.
💡
Conclusion & Impact:There is a need for studies in a large number of patients and specific groups evaluating the relationship with disease activity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Cardiovascular features in rheumatoid arthritis (RA) are comman. These complications include pericarditis, myocarditis, cardiac amyloidosis, coronary vasculitis, arrhythmia and valve disease, as well as congestive heart failure and ischemic heart disease. For this reason, mortality and morbidity are more common in patients with RA than in the normal population. In recent years, N-terminal pro-brain natriuretic peptide (NT-proBNP) has been used to identify cardiac failure. In this study, we aimed to determine the relationship between disease activity and NT-proBNP levels in patients with RA. Material and Methods: Serum NT-proBNP, erythrocyte sedimentation rate, C-reactive protein levels were measured in 77 patients with RA and 31 healthy control groups without cardiac disease history. NT-proBNP levels were compared according to DAS 28 score. Results: There was a positive correlation between NT-proBNP levels of patients and age, body mass index and C reactive protein levels. There was no significant difference between NT-proBNP levels and disease activity. Conclusion: The NT-proBNP correlates with the C-reactive protein. There is a need for studies in a large number of patients and specific groups evaluating the relationship with disease activity.

Özet

Amaç: Romatoid artrit (RA)’te kardiyovasküler komplikasyonlar sık ortaya çıkmaktadır. Bu komplikasyonlar arasında perikardit, miyokardit, kardiyak amiloidoz, koroner vaskülit, aritmi ve kapak hastalığı olduğu gibi konjestif kalp yetmezliği ve iskemik kalp hastalıkları da bulunmaktadır. Bu nedenle romatoid artritli hastalarda normal popülasyona göre mortalite ve morbidite daha sık görülmektedir. Son yıllarda N terminal pro beyin natriüretik peptid (NT-proBNP) kardiyak yetmezliğinin tanısında kullanılmaktadır. Biz bu çalışmada RA’li hastalarda hastalık aktivitesi ile NT-proBNP seviyeleri arasındaki ilişkiyi belirlemeyi amaçladık. Gereç ve Yöntem: Kalp hastalığı öyküsü olmayan 77 RA’li hasta ve 31 sağlıklı kontrol grubunda serum NT-proBNP, eritrosit sedimentasyon hızı, C reaktif protein düzeyleri ölçüldü. DAS 28 skoruna göre NT-proBNP düzeyleri karşılaştırıldı. Bulgular: Hastaların NT-proBNP düzeyleri ile yaş, beden kitle indeksi ve C reaktif protein düzeyleri arasında pozitif korelasyon vardı. NT-proBNP düzeyleri ile hastalık aktivitesi arasında anlamlı bir farklılık tespit edilmedi. Sonuç: NT-proBNP düzeyleri ile C reaktif protein düzeyleri arasında korelasyon vardır. Hastalık aktivitesi ile arasındaki ilişkiyi değerlendiren çok sayıda hasta ve spesifik gruplarda yapılmış çalışmalara ihtiyaç vardır.

🔖

Cite This Article

UĞUR, S., KURTOĞLU, A., BÜTÜN, B. (2019). Kalp hastalığı olmayan romatoid artritli hastalarda hastalık aktivitesi ile nt-pro bnp düzeyleri arasındaki ilişki. Genel Tıp Dergisi, Cilt: 29 - Sayı: 1, 14–18. https://ajindex.com/articles/159605

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gupta S. Review Article. When to initiate RRT in patients with AKI-Does timing matter? Apollo Medicine 2013; 10: 41-6.
  2. Bagshaw SM, Uchino S, Bellomo R, et al. For the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. Journal of Critical Care 2009; 24: 129–40.
  3. Leung AKH, Yan WW. Review Article. Renal replacement therapy in critically ill patients. Hong Kong Med J 2009; 15: 122-9. Uchino S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006; 12: 538-43.
  4. Mendonca AD, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000; 26: 915-21.
  5. Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 2008; 109: 182-7.
  6. Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Critical Care 2011; 15: R72. Leite TT, Macedo E, Pereira SM, et al. Timing of renal replacement therapy initiation by AKIN classification system. Critical Care 2013; 17: R62. Bagshaw SM, Wald R, Barton J, et al. Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury—A prospective multicenter observational study. Journal of Critical Care 2012; 27: 268–75.
  7. Drummond AD, Bellamy MC. Renal replacement therapy in the intensive care unit. Current Anaesthesia Critical Care 2010; 21: 69–74.
  8. John S, Eckardt KU. Renal Replacement Strategies in the ICU. Chest 2007; 132: 1379–88.
  9. John S, Eckardt KU. Renal Replacement Therapy in the Treatment of Acute Renal Failure-Intermittent and Continuous. Seminars in Dialysis 2006: 19: 455–64.
  10. Matson J, Zydney A, Honore PM. Blood filtration: new opportunities and the implications of systems biology. Crit Care Resusc 2004; 6: 209-17.
  11. Clark E, Wald R, Walsh M, Bagshaw SM. Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant 2012; 27: 2761–7.
  12. Ricci Z, Ronco C. Timing, dose and mode of dialysis in acute kidney injury. Current Opinion in Critical Care 2011; 17: 556– 61. Palevsky PM. Indications and timing of renal replacement therapy in acute kidney injury. Cri